Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
The Journal of Urology
|
October 1, 1994
Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors
E B Fernandez, I A Sesterhenn, W F McCarthy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 1, 1989
Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques
T T Antonovych, S G Sabnis, S M Tuur, et al.
The Journal of Urology
|
October 1, 1996
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer
J J Bauer, I A Sesterhenn, F K Mostofi, et al.
Der Urologe. Ausg. A
|
January 10, 1998
[Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?]
A Heidenreich, S Neubauer, F K Mostofi, et al.
Prostate Cancer and Prostatic Diseases
|
January 12, 2005
Risk of prostate cancer and family history of cancer: a population-based study in China
Y Bai, Y-T Gao, J Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy
J J Bauer, I A Sesterhenn, K F Mostofi, et al.
The American Journal of Surgical Pathology
|
November 10, 1998
Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature
D B Flieder, M N Koss, A Nicholson, et al.
International Journal of Cancer
|
May 2, 1997
Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector
K Asgari, I A Sesterhenn, D G McLeod, et al.
The Journal of Urology
|
September 1, 1996
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy
M C Bettencourt, J J Bauer, I A Sesterhenn, et al.
Prostate Cancer and Prostatic Diseases
|
September 8, 2010
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D Hawksworth, L Ravindranath, Y Chen, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
The Journal of Urology
|
October 1, 1994
Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors
E B Fernandez, I A Sesterhenn, W F McCarthy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 1, 1989
Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques
T T Antonovych, S G Sabnis, S M Tuur, et al.
The Journal of Urology
|
October 1, 1996
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer
J J Bauer, I A Sesterhenn, F K Mostofi, et al.
Der Urologe. Ausg. A
|
January 10, 1998
[Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?]
A Heidenreich, S Neubauer, F K Mostofi, et al.
Prostate Cancer and Prostatic Diseases
|
January 12, 2005
Risk of prostate cancer and family history of cancer: a population-based study in China
Y Bai, Y-T Gao, J Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy
J J Bauer, I A Sesterhenn, K F Mostofi, et al.
The American Journal of Surgical Pathology
|
November 10, 1998
Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature
D B Flieder, M N Koss, A Nicholson, et al.
International Journal of Cancer
|
May 2, 1997
Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector
K Asgari, I A Sesterhenn, D G McLeod, et al.
The Journal of Urology
|
September 1, 1996
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy
M C Bettencourt, J J Bauer, I A Sesterhenn, et al.
Prostate Cancer and Prostatic Diseases
|
September 8, 2010
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D Hawksworth, L Ravindranath, Y Chen, et al.
Page
of 11